Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
30 participants
OBSERVATIONAL
2025-05-01
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation Between the Visual Acuity & the OCT Pattern of Macular Edema Secondary to RVO
NCT03489915
Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19
NCT05650905
Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)
NCT04437082
Vitreomacular Interface Abnormalities in Diabetic Retinopathy Using OCT
NCT03686436
OCT in Retinal Vein Occlusions
NCT01992575
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Assess the correlation between baseline OCT biomarkers and visual acuity improvements over time.
Study Design Type: Cross-sectional study.
Setting: Conducted at several eye care centers in Egypt.
Participants Inclusion Criteria: Adults with branch or central RVO, macular edema confirmed by OCT, and no prior RVO in the affected eye.
Exclusion Criteria: Other retinal diseases, recent intraocular surgery, or significant media opacities.
Procedures Informed Consent and History Taking.
Ophthalmologic Examination: Includes BCVA, IOP, slit-lamp biomicroscopy, and fundus examination.
OCT Imaging: Using NIDEK RS-330 Retina scan duo 2 (SD-OCT) to assess macular changes.
OCT Image Evaluation: Classification of macular edema types and assessment of biomarkers like subretinal fluid and cystoid changes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults with branch or central RVO, macular edema confirmed by OCT, and no prior RVO in the affected
Adults aged 18 years or older.
Patients diagnosed with branch or central retinal vein occlusion.
Patients with macular edema confirmed by OCT due to vein occlusion.
Patients with no prior history of RVO in the affected eye.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Patients diagnosed with branch or central retinal vein occlusion.
Patients with macular edema confirmed by OCT due to vein occlusion.
Patients with no prior history of RVO in the affected eye.
Exclusion Criteria
History of intraocular surgery within the last three months.
Presence of significant media opacities (e.g., dense cataract, vitreous hemorrhage) that interfere with OCT imaging.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mayar Adel Francis
resident at the ophtalmology department
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OCT in retinal vein occlusion
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.